Golfyeti you summarized it well. Hard to figure out why they waited so long to make a statement as simple as:
"eGFR changes over time were not different."
There was hardly anything new in this entire presentation. I am very disappointed. It is essentially a rehash of November 2019 AHA and corporate update.
BDAZ